Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Overweight women with PCOS are more likely to have excess male hormones.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

The document concludes that managing PCOS involves lifestyle changes, medication for symptoms, and weight loss for fertility improvement.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

A misdiagnosed case of HAIR-AN syndrome led to unnecessary surgeries and highlighted the importance of correct diagnosis and treatment.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.